About: Sol-Gel Technologies Ltd., together with its subsidiary Sol-Gel Technologies Inc., develops topical dermatological drugs for patients with severe skin conditions in Israel, China, Switzerland, Canada, the United States and internationally. The company offers Twyneo, a once-daily, non-antibiotic topical cream for the treatment of acne vulgaris; and Epsolay, a once-daily topical cream for the treatment of papulopustular (subtype II) rosacea. It also develops SGT-610 that is in Phase 3 clinical trials for the treatment of Gorlin Syndrome; and SGT-210, which has completed Phase I clinical trial, to treat olmsted syndrome. It has collaboration with Padagis Israel Pharmaceuticals Ltd; and license agreements with Galderma Holding SA and Searchlight Pharma Inc. Sol-Gel Technologies Ltd. was incorporated in 1997 and is headquartered in Ness Ziona, Israel.
Sector: Healthcare
Industry: Biotechnology
Latest price: $65.11 (-4.74%)
SLGL NASDAQ Sol Gel Technologies Ltd
Sol Gel Technologies Ltd share price
SLGL price activity
Last Price
$68.350
Change (24hr)
-0.31 USD (0.45%)
Volume
33.52K
Volume (4w avg)
-
Open
$69.49
Day Range
$67.14 - $70.15
Previous Close
$68.66
Last Trade
30 Oct, 8:00 pm GMT+0
Delayed
30 Oct, 8:00 pm GMT+0
SLGL price performance
Delayed
30 Oct, 8:00 pm GMT+0
SLGL Market Signals